Literature DB >> 9152742

Leptin concentrations and insulin sensitivity in normoglycemic men.

S M Haffner1, H Miettinen, L Mykkänen, P Karhapää, D L Rainwater, M Laakso.   

Abstract

OBJECTIVE: Leptin is a hormone regulating weight in the mouse. Leptin regulates food intake and appetite. Leptin concentrations are increased in obese individuals suggesting resistance to its effect. However, there is considerable variability in leptin levels at each level of adiposity suggesting that environmental and genetic factors may regulate leptin concentrations. We examined whether subjects with decreased insulin sensitivity have increased leptin levels.
METHODS: We used a radioimmunoassay to measure serum leptin levels and the hyperinsulinemic euglycemic clamp (with indirect calorimetry) to measure insulin sensitivity in 87 normoglycemic relatively lean men.
RESULTS: Leptin levels were significantly correlated with fasting insulin (r = 0.58), insulin area (r = 0.45), overall (r = -0.57), non-oxidative (r = -0.51) and oxidative (r = -0.51) whole body glucose disposal (all P-values < 0.001). After adjustment for body mass index, leptin levels remained significantly correlated with fasting insulin (r = 0.44), insulin area (r = 0.40), overall (r = -0.40), non-oxidative (r = -0.28) and oxidative (r = -0.33) whole body glucose disposal although the magnitude of the associations was considerably decreased. Leptin levels were significantly related to insulin sensitivity in both less obese and more obese subjects.
CONCLUSIONS: We conclude that leptin concentrations are related to insulin resistance and insulin concentrations in relatively lean normoglycemic men and these associations are to some extent independent of body mass index. Thus, subjects with insulin resistance may be relatively resistant to the effects of leptin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152742     DOI: 10.1038/sj.ijo.0800419

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  7 in total

Review 1.  Plasma leptin and exercise: recent findings.

Authors:  Matthew W Hulver; Joseph A Houmard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 2.  The effect of in-utero undernutrition on the insulin resistance syndrome.

Authors:  Delphine Jaquet; Juliane Leger; Paul Czernichow; Claire Levy-Marchal
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 3.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment.

Authors:  E Stip; O V Lungu; K Anselmo; G Letourneau; A Mendrek; B Stip; O Lipp; P Lalonde; L A Bentaleb
Journal:  Transl Psychiatry       Date:  2012-06-19       Impact factor: 6.222

5.  Pilot study on the effects of a 2-week hiking vacation at moderate versus low altitude on plasma parameters of carbohydrate and lipid metabolism in patients with metabolic syndrome.

Authors:  Ivana Gutwenger; Georg Hofer; Anna K Gutwenger; Marco Sandri; Christian J Wiedermann
Journal:  BMC Res Notes       Date:  2015-03-28

6.  Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial.

Authors:  Esben S Lauritzen; Ulla Kampmann; Mette G B Pedersen; Lise-Lotte Christensen; Niels Jessen; Niels Møller; Julie Støy
Journal:  J Pineal Res       Date:  2022-06-09       Impact factor: 12.081

7.  Leptin therapy, insulin sensitivity, and glucose homeostasis.

Authors:  Gilberto Paz-Filho; Claudio Mastronardi; Ma-Li Wong; Julio Licinio
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.